Diversity in expression and prognostic significance of GI/S cyclins in human primary lung carcinomas

Journal of Pathology

Volumn 199, Issue 2, 2003, Pages 208-220

  Dobashi, Yoh ^a   Jiang, Shi Xu ^a   Shoji, Mitsuhiko ^a   Morinaga, Shojiroh ^b,c   Kameya, Toru ^a  

^a Kitasato University   (Japan)

^b SAISEIKAI CENTRAL HOSPITAL   (Japan)

^c KITASATO INSTITUTE HOSPITAL   (Japan)

Author keywords

Cdk2; Cyclins; Flow cytometry; Immunohistochemistry; Non small cell lung carcinoma; Quantitative RT PCR

Indexed keywords

CYCLIN A; CYCLIN DEPENDENT KINASE 2; CYCLIN E; CYCLINE; MESSENGER RNA;

ADULT; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN METABOLISM; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CDC2-CDC28 KINASES; CYCLIN A; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM;

EID: 0037316746     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1247     Document Type: Article

References (36)

1. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994; 79: 551-555.
2. Hunter T, Pines J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 1994; 79: 573-582.
3. Ohtsubo M, Roberts JM. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 1993; 259: 1908-1912.
4. Diest PJ, Michalides RJ, Jannink I, et al. Cyclin D1 expression in invasive breast cancer. Correlation and prognostic value. Am J Pathol 1995; 150: 705-711.
5. Dobashi Y, Kudoh T, Matsumine A, Toyoshima K, Akiyama T. Constitutive overexpression of cdk2 inhibits neuronal differentiation of rat pheochromocytoma PC12 cells. J Biol Chem 1995; 270: 23 031-23 037.
6. Keyomarsi K, Conte D, Toyofuku W, Fox MP. Deregulation of cyclin E in breast cancer. Oncogene 1995; 11: 941-950.
7. Volm M, Koomagi R, Mattern J, Stammler G. Cyclin A is associated with an unfavorable outcome in patients with non-small-cell lung carcinomas. Br J Cancer 1997; 75: 1774-1778.
8. Dobashi Y, Shoji M, Jiang SX, Kobayashi M, Kawakubo Y, Kameya T. Active cyclin A-cdk2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas. Am J Pathol 1998; 153: 863-872.
9. Volm M, Koomagi R, Rittgen W. Clinical implications of cyclins, cyclin-dependent kinases, RB and E2F1 in squamous-cell lung carcinoma. Int J Cancer 1998; 79: 294-299.
10. Aaltomaa S, Lipponen P, Ala-Opas M, Eskelinen M, Syrjanen K, Kosma VM. Expression of cyclins A and D and p21 (waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. Br J Cancer 1999; 80: 2001-2007.
11. Handa K, Yamakawa M, Takeda H, Kimura S, Takahashi T. Expression of cell cycle markers in colorectal carcinoma: superiority of cyclin A as an indicator of poor prognosis. Int J Cancer 1999; 84: 225-233.
12. Kitahara K, Yasui W, Kuniyasu H, et al. Concurrent amplification of cyclin E and cdk2 genes in colorectal carcinomas. Int J Cancer 1995; 62: 25-28.
13. Marone M, Scambia G, Giannitelli C, et al. Analysis of cyclin E and cdk2 in ovarian cancer: gene amplification and RNA overexpression. Int J Cancer 1998; 75: 34-39.
14. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB. Cyclin E, a potential prognostic marker for breast carcinoma. Cancer Res 1994; 54: 380-385.
15. Takano Y, Kato Y, van Diest PJ, Masuda M, Mitomi H, Okayasu I. Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am J Pathol 2000; 156: 585-594.
16. Del Pizzo J, Borkowski A, Jacobs SC, Kyprianou N. Loss of cell cycle regulators in p27 (Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival. Am J Pathol 1999; 155: 1129-1136.
17. Bito T, Ueda M, Ito A, Ichihashi M. Less expression of cyclin E in cutaneous squamous cell carcinomas than in benign and premalignant keratinocytic lesions. J Cutan Pathol 1997; 24: 305-308.
18. Fukuse T, Hirata T, Naiki H, Hitomi S, Wada H. Prognostic significance of cyclin E overexpression in resected non-small cell lung cancer. Cancer Res 2000; 60: 242-244.
19. Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. (in collaboration with LH Sobin and pathologists from 14 countries). The World Health Organization Histological Typing of Lung and Pleural Tumors (3rd edn). Springer: New York, 1999.
20. Sobin LH, Wittekind CH (eds). International Union Against Cancer. TNM Classification of Malignant Tumors. (5th fully revised edn). Wiley-Liss: New York, 1997; 91-97.
21. Shoji M, Dobashi Y, Morinaga S, Jiang SX, Kameya T. Mode of tumor extension and cell proliferation in adenocarcinomas of the lung. Am J Pathol 1999; 154: 909-918.
22. Noguchi T, Dobashi Y, Minehara H, Itoman M, Kameya T. Involvement of cyclins in cell proliferation and their clinical implications in soft tissue smooth muscle tumors. Am J Pathol 2000; 156: 2135-2147.
23. Dobashi Y, Noguchi T, Nasuno S, Katayama K, Kameya T. CDK-inhibitors-associated kinase activity, a possible determinant of malignant potential in smooth muscle tumors of the external soft tissue. Int J Cancer 2001; 94: 353-362.
24. Courdi A, Hery M, Chauvel P, Gioanni J, Namer M, Demard F. Prognostic values of continuous variables in breast cancer and head and neck cancer. Dependence on the cut-off level. Br J Cancer 1988; 58: 88-90.
25. Tubiana M, Pejovic MH, Chavaudra N, Contesso G, Malaise EP. The long-term prognostic significance of the thymidine labeling index in breast cancer. Int J Cancer 1984; 33: 441-449.
26. Dobashi Y, Shoji M, Kondo E, Akiyama T, Kameya T. CDK4, a possible critical regulator of apoptosis in rat pheochromocytoma PC12 cells. Biochem Biophys Res Commun 1998; 253: 609-613.
27. Dressler LG, Seamer LC, Owens MA, Clark GM, McGuire WL. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 1988; 61: 420-426.
28. Bloomquist BT, Eipper BT, Mains RE. Prohormone converting enzymes: regulation and evaluation of function using antisense RNA. Mol Endocrinol 1991; 5: 2014-2024.
29. Harwell RM, Porter DC, Danes C, Keyomarsi K. Processing of cyclin E differs between normal and tumor breast cells. Cancer Res 2000; 60: 481-489.
30. Lonardo F, Rusch V, Langenfeld J, Dmitrovsky E, Klimstra DS. Overexpression of cyclins D1 and E is frequent in bronchial preneoplasia and precedes squamous cell carcinoma development. Cancer Res 1999; 59: 2470-2476.
31. Vollenweider-Zerargui L, Barrelet L, Wong Y, Lemarchand-beraud T, Gomez F. The predictive value of estrogen and progesterone receptors' concentration on the clinical behavior of breast cancer in women. Clinical correlation on 547 patients. Cancer 1986; 57: 1171-1176.
32. Nakayama K, Nagahama H, Minamishima YA, et al. Targeted disruption of Skp2 results in accumulation of cyclin E and p27 (kip1), polyploidy and centrosome overduplication. EMBO J 2000; 19: 2069-2081.
33. Tsukamoto S, Sugio K, Sakada T, Ushijima C, Yamazaki K, Sugimachi K. Reduced expression of cell-cycle regulator p27 (Kip1) correlates with a shortened survival in non-small cell lung cancer. Lung Cancer 2001; 34: 83-90.
34. Catzavelos C, Tsao MS, DeBoer G, Bhattacharya N, Shepherd FA, Slingerland JM. Reduced expression of the cell cycle inhibitor p27Kip1 in non-small cell lung carcinoma: a prognostic factor independent of Ras. Cancer Res 1999; 59: 684-688.
35. Hayashi H, Ito T, Yazawa T, et al. Reduced expression of p27/Kip1 is associated with the development of pulmonary adenocarcinoma. J Pathol 2000; 192: 26-31.
36. Hayashi H, Ogawa N, Ishiwa N, et al. High cyclin E and low p27/Kip1 expression are potentially poor prognostic factors in lung adenocarcinoma patients. Lung Cancer 2001; 34: 59-65.